Pharmaceuticals

Global Nuclear Medicine/Radiopharmaceuticals Market Report 2019, Competitive Landscape, Trends and Opportunities

  • MAI3216709
  • 111 Pages
  • July 2019
  • Pharmaceuticals
Download Sample    Get Discount   
 
The Nuclear Medicine/Radiopharmaceuticals market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2026.

The report mainly studies the size, recent trends and development status of the Nuclear Medicine/Radiopharmaceuticals market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Nuclear Medicine/Radiopharmaceuticals market.

Major players in the global Nuclear Medicine/Radiopharmaceuticals market include:

Lantheus Medical Imaging

Bayer Healthcare

Nordion

Cardinal Health

Mallinckrodt PLC

GE Healthcare

Eczcibasi-Monrol Nuclear Products

IBA Molecular Imaging

Advanced Accelerator Applications S.A.

Bracco Imaging S.P.A

On the basis of types, the Nuclear Medicine/Radiopharmaceuticals market is primarily split into:

Diagnosis

Therapeutics

On the basis of applications, the market covers:

Alpha radiation therapy

Beta radiation therapy

Brachytherapy

Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:

United States

Europe (Germany, UK, France, Italy, Spain, Russia, Poland)

China

Japan

India

Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)

Central and South America (Brazil, Mexico, Colombia)

Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)

Other Regions

Chapter 1 provides an overview of Nuclear Medicine/Radiopharmaceuticals market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Nuclear Medicine/Radiopharmaceuticals market by type, application, and region are also presented in this chapter.

Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.

Chapter 3 provides a full-scale analysis of major players in Nuclear Medicine/Radiopharmaceuticals industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.

Chapter 4 gives a worldwide view of Nuclear Medicine/Radiopharmaceuticals market. It includes production, market share revenue, price, and the growth rate by type.

Chapter 5 focuses on the application of Nuclear Medicine/Radiopharmaceuticals, by analyzing the consumption and its growth rate of each application.

Chapter 6 is about production, consumption, export, and import of Nuclear Medicine/Radiopharmaceuticals in each region.

Chapter 7 pays attention to the production, revenue, price and gross margin of Nuclear Medicine/Radiopharmaceuticals in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.

Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.

Chapter 9 introduces the industrial chain of Nuclear Medicine/Radiopharmaceuticals. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.

Chapter 10 provides clear insights into market dynamics.

Chapter 11 prospects the whole Nuclear Medicine/Radiopharmaceuticals market, including the global production and revenue forecast, regional forecast. It also foresees the Nuclear Medicine/Radiopharmaceuticals market by type and application.

Chapter 12 concludes the research findings and refines all the highlights of the study.

Chapter 13 introduces the research methodology and sources of research data for your understanding.

Years considered for this report:

Historical Years: 2014-2018

Base Year: 2019

Estimated Year: 2019

Forecast Period: 2019-2026

Table of Contents

1 Nuclear Medicine/Radiopharmaceuticals Market Overview

1.1 Product Overview and Scope of Nuclear Medicine/Radiopharmaceuticals

1.2 Nuclear Medicine/Radiopharmaceuticals Segment by Type

1.2.1 Global Nuclear Medicine/Radiopharmaceuticals Production and CAGR (%) Comparison by Type (2014-2026)

1.2.2 The Market Profile of Diagnosis

1.2.3 The Market Profile of Therapeutics

1.3 Global Nuclear Medicine/Radiopharmaceuticals Segment by Application

1.3.1 Nuclear Medicine/Radiopharmaceuticals Consumption (Sales) Comparison by Application (2014-2026)

1.3.2 The Market Profile of Alpha radiation therapy

1.3.3 The Market Profile of Beta radiation therapy

1.3.4 The Market Profile of Brachytherapy

1.4 Global Nuclear Medicine/Radiopharmaceuticals Market by Region (2014-2026)

1.4.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)

1.4.2 United States Nuclear Medicine/Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.3 Europe Nuclear Medicine/Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.3.1 Germany Nuclear Medicine/Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.3.2 UK Nuclear Medicine/Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.3.3 France Nuclear Medicine/Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.3.4 Italy Nuclear Medicine/Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.3.5 Spain Nuclear Medicine/Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.3.6 Russia Nuclear Medicine/Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.3.7 Poland Nuclear Medicine/Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.4 China Nuclear Medicine/Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.5 Japan Nuclear Medicine/Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.6 India Nuclear Medicine/Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.7 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.7.1 Malaysia Nuclear Medicine/Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.7.2 Singapore Nuclear Medicine/Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.7.3 Philippines Nuclear Medicine/Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.7.4 Indonesia Nuclear Medicine/Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.7.5 Thailand Nuclear Medicine/Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.7.6 Vietnam Nuclear Medicine/Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.8 Central and South America Nuclear Medicine/Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.8.1 Brazil Nuclear Medicine/Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.8.2 Mexico Nuclear Medicine/Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.8.3 Colombia Nuclear Medicine/Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.9 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.9.1 Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.9.2 United Arab Emirates Nuclear Medicine/Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.9.3 Turkey Nuclear Medicine/Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.9.4 Egypt Nuclear Medicine/Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.9.5 South Africa Nuclear Medicine/Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.9.6 Nigeria Nuclear Medicine/Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.5 Global Market Size (Value) of Nuclear Medicine/Radiopharmaceuticals (2014-2026)

1.5.1 Global Nuclear Medicine/Radiopharmaceuticals Revenue Status and Outlook (2014-2026)

1.5.2 Global Nuclear Medicine/Radiopharmaceuticals Production Status and Outlook (2014-2026)

2 Global Nuclear Medicine/Radiopharmaceuticals Market Landscape by Player

2.1 Global Nuclear Medicine/Radiopharmaceuticals Production and Share by Player (2014-2019)

2.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Player (2014-2019)

2.3 Global Nuclear Medicine/Radiopharmaceuticals Average Price by Player (2014-2019)

2.4 Nuclear Medicine/Radiopharmaceuticals Manufacturing Base Distribution, Sales Area and Product Type by Player

2.5 Nuclear Medicine/Radiopharmaceuticals Market Competitive Situation and Trends

2.5.1 Nuclear Medicine/Radiopharmaceuticals Market Concentration Rate

2.5.2 Nuclear Medicine/Radiopharmaceuticals Market Share of Top 3 and Top 6 Players

2.5.3 Mergers & Acquisitions, Expansion

3 Players Profiles

3.1 Lantheus Medical Imaging

3.1.1 Lantheus Medical Imaging Basic Information, Manufacturing Base, Sales Area and Competitors

3.1.2 Nuclear Medicine/Radiopharmaceuticals Product Profiles, Application and Specification

3.1.3 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceuticals Market Performance (2014-2019)

3.1.4 Lantheus Medical Imaging Business Overview

3.2 Bayer Healthcare

3.2.1 Bayer Healthcare Basic Information, Manufacturing Base, Sales Area and Competitors

3.2.2 Nuclear Medicine/Radiopharmaceuticals Product Profiles, Application and Specification

3.2.3 Bayer Healthcare Nuclear Medicine/Radiopharmaceuticals Market Performance (2014-2019)

3.2.4 Bayer Healthcare Business Overview

3.3 Nordion

3.3.1 Nordion Basic Information, Manufacturing Base, Sales Area and Competitors

3.3.2 Nuclear Medicine/Radiopharmaceuticals Product Profiles, Application and Specification

3.3.3 Nordion Nuclear Medicine/Radiopharmaceuticals Market Performance (2014-2019)

3.3.4 Nordion Business Overview

3.4 Cardinal Health

3.4.1 Cardinal Health Basic Information, Manufacturing Base, Sales Area and Competitors

3.4.2 Nuclear Medicine/Radiopharmaceuticals Product Profiles, Application and Specification

3.4.3 Cardinal Health Nuclear Medicine/Radiopharmaceuticals Market Performance (2014-2019)

3.4.4 Cardinal Health Business Overview

3.5 Mallinckrodt PLC

3.5.1 Mallinckrodt PLC Basic Information, Manufacturing Base, Sales Area and Competitors

3.5.2 Nuclear Medicine/Radiopharmaceuticals Product Profiles, Application and Specification

3.5.3 Mallinckrodt PLC Nuclear Medicine/Radiopharmaceuticals Market Performance (2014-2019)

3.5.4 Mallinckrodt PLC Business Overview

3.6 GE Healthcare

3.6.1 GE Healthcare Basic Information, Manufacturing Base, Sales Area and Competitors

3.6.2 Nuclear Medicine/Radiopharmaceuticals Product Profiles, Application and Specification

3.6.3 GE Healthcare Nuclear Medicine/Radiopharmaceuticals Market Performance (2014-2019)

3.6.4 GE Healthcare Business Overview

3.7 Eczcibasi-Monrol Nuclear Products

3.7.1 Eczcibasi-Monrol Nuclear Products Basic Information, Manufacturing Base, Sales Area and Competitors

3.7.2 Nuclear Medicine/Radiopharmaceuticals Product Profiles, Application and Specification

3.7.3 Eczcibasi-Monrol Nuclear Products Nuclear Medicine/Radiopharmaceuticals Market Performance (2014-2019)

3.7.4 Eczcibasi-Monrol Nuclear Products Business Overview

3.8 IBA Molecular Imaging

3.8.1 IBA Molecular Imaging Basic Information, Manufacturing Base, Sales Area and Competitors

3.8.2 Nuclear Medicine/Radiopharmaceuticals Product Profiles, Application and Specification

3.8.3 IBA Molecular Imaging Nuclear Medicine/Radiopharmaceuticals Market Performance (2014-2019)

3.8.4 IBA Molecular Imaging Business Overview

3.9 Advanced Accelerator Applications S.A.

3.9.1 Advanced Accelerator Applications S.A. Basic Information, Manufacturing Base, Sales Area and Competitors

3.9.2 Nuclear Medicine/Radiopharmaceuticals Product Profiles, Application and Specification

3.9.3 Advanced Accelerator Applications S.A. Nuclear Medicine/Radiopharmaceuticals Market Performance (2014-2019)

3.9.4 Advanced Accelerator Applications S.A. Business Overview

3.10 Bracco Imaging S.P.A

3.10.1 Bracco Imaging S.P.A Basic Information, Manufacturing Base, Sales Area and Competitors

3.10.2 Nuclear Medicine/Radiopharmaceuticals Product Profiles, Application and Specification

3.10.3 Bracco Imaging S.P.A Nuclear Medicine/Radiopharmaceuticals Market Performance (2014-2019)

3.10.4 Bracco Imaging S.P.A Business Overview

4 Global Nuclear Medicine/Radiopharmaceuticals Production, Revenue (Value), Price Trend by Type

4.1 Global Nuclear Medicine/Radiopharmaceuticals Production and Market Share by Type (2014-2019)

4.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Type (2014-2019)

4.3 Global Nuclear Medicine/Radiopharmaceuticals Price by Type (2014-2019)

4.4 Global Nuclear Medicine/Radiopharmaceuticals Production Growth Rate by Type (2014-2019)

4.4.1 Global Nuclear Medicine/Radiopharmaceuticals Production Growth Rate of Diagnosis (2014-2019)

4.4.2 Global Nuclear Medicine/Radiopharmaceuticals Production Growth Rate of Therapeutics (2014-2019)

5 Global Nuclear Medicine/Radiopharmaceuticals Market Analysis by Application

5.1 Global Nuclear Medicine/Radiopharmaceuticals Consumption and Market Share by Application (2014-2019)

5.2 Global Nuclear Medicine/Radiopharmaceuticals Consumption Growth Rate by Application (2014-2019)

5.2.1 Global Nuclear Medicine/Radiopharmaceuticals Consumption Growth Rate of Alpha radiation therapy (2014-2019)

5.2.2 Global Nuclear Medicine/Radiopharmaceuticals Consumption Growth Rate of Beta radiation therapy (2014-2019)

5.2.3 Global Nuclear Medicine/Radiopharmaceuticals Consumption Growth Rate of Brachytherapy (2014-2019)

6 Global Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export, Import by Region (2014-2019)

6.1 Global Nuclear Medicine/Radiopharmaceuticals Consumption by Region (2014-2019)

6.2 United States Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export, Import (2014-2019)

6.3 Europe Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export, Import (2014-2019)

6.4 China Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export, Import (2014-2019)

6.5 Japan Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export, Import (2014-2019)

6.6 India Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export, Import (2014-2019)

6.7 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export, Import (2014-2019)

6.8 Central and South America Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export, Import (2014-2019)

6.9 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export, Import (2014-2019)

7 Global Nuclear Medicine/Radiopharmaceuticals Production, Revenue (Value) by Region (2014-2019)

7.1 Global Nuclear Medicine/Radiopharmaceuticals Production and Market Share by Region (2014-2019)

7.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Market Share by Region (2014-2019)

7.3 Global Nuclear Medicine/Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

7.4 United States Nuclear Medicine/Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

7.5 Europe Nuclear Medicine/Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

7.6 China Nuclear Medicine/Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

7.7 Japan Nuclear Medicine/Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

7.8 India Nuclear Medicine/Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

7.9 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

7.10 Central and South America Nuclear Medicine/Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

7.11 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

8 Nuclear Medicine/Radiopharmaceuticals Manufacturing Analysis

8.1 Nuclear Medicine/Radiopharmaceuticals Key Raw Materials Analysis

8.1.1 Key Raw Materials Introduction

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Manufacturing Cost Analysis

8.2.1 Labor Cost Analysis

8.2.2 Manufacturing Cost Structure Analysis

8.3 Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceuticals

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Nuclear Medicine/Radiopharmaceuticals Industrial Chain Analysis

9.2 Raw Materials Sources of Nuclear Medicine/Radiopharmaceuticals Major Players in 2018

9.3 Downstream Buyers

10 Market Dynamics

10.1 Drivers

10.2 Restraints

10.3 Opportunities

10.3.1 Advances in Innovation and Technology for Nuclear Medicine/Radiopharmaceuticals

10.3.2 Increased Demand in Emerging Markets

10.4 Challenges

10.4.1 The Performance of Alternative Product Type is Getting Better and Better

10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices

10.5 Porter’s Five Forces Analysis

10.5.1 Threat of New Entrants

10.5.2 Threat of Substitutes

10.5.3 Bargaining Power of Suppliers

10.5.4 Bargaining Power of Buyers

10.5.5 Intensity of Competitive Rivalry

11 Global Nuclear Medicine/Radiopharmaceuticals Market Forecast (2019-2026)

11.1 Global Nuclear Medicine/Radiopharmaceuticals Production, Revenue Forecast (2019-2026)

11.1.1 Global Nuclear Medicine/Radiopharmaceuticals Production and Growth Rate Forecast (2019-2026)

11.1.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate Forecast (2019-2026)

11.1.3 Global Nuclear Medicine/Radiopharmaceuticals Price and Trend Forecast (2019-2026)

11.2 Global Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export and Import Forecast by Region (2019-2026)

11.2.1 United States Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export and Import Forecast (2019-2026)

11.2.2 Europe Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export and Import Forecast (2019-2026)

11.2.3 China Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export and Import Forecast (2019-2026)

11.2.4 Japan Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export and Import Forecast (2019-2026)

11.2.5 India Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export and Import Forecast (2019-2026)

11.2.6 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export and Import Forecast (2019-2026)

11.2.7 Central and South America Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export and Import Forecast (2019-2026)

11.2.8 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export and Import Forecast (2019-2026)

11.3 Global Nuclear Medicine/Radiopharmaceuticals Production, Revenue and Price Forecast by Type (2019-2026)

11.4 Global Nuclear Medicine/Radiopharmaceuticals Consumption Forecast by Application (2019-2026)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology

13.2 Research Data Source

List of Tables and Figures

Figure Nuclear Medicine/Radiopharmaceuticals Product Picture

Table Global Nuclear Medicine/Radiopharmaceuticals Production and CAGR (%) Comparison by Type

Table Profile of Diagnosis

Table Profile of Therapeutics

Table Nuclear Medicine/Radiopharmaceuticals Consumption (Sales) Comparison by Application (2014-2026)

Table Profile of Alpha radiation therapy

Table Profile of Beta radiation therapy

Table Profile of Brachytherapy

Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size (Value) and CAGR (%) (2014-2026)

Figure United States Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Europe Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Germany Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure UK Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure France Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Italy Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Spain Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Russia Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Poland Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure China Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Japan Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure India Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Southeast Asia Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Malaysia Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Singapore Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Philippines Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Indonesia Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Thailand Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Vietnam Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Central and South America Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Brazil Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Mexico Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Colombia Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure United Arab Emirates Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Turkey Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Egypt Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure South Africa Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Nigeria Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Global Nuclear Medicine/Radiopharmaceuticals Production Status and Outlook (2014-2026)

Table Global Nuclear Medicine/Radiopharmaceuticals Production by Player (2014-2019)

Table Global Nuclear Medicine/Radiopharmaceuticals Production Share by Player (2014-2019)

Figure Global Nuclear Medicine/Radiopharmaceuticals Production Share by Player in 2018

Table Nuclear Medicine/Radiopharmaceuticals Revenue by Player (2014-2019)

Table Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Player (2014-2019)

Table Nuclear Medicine/Radiopharmaceuticals Price by Player (2014-2019)

Table Nuclear Medicine/Radiopharmaceuticals Manufacturing Base Distribution and Sales Area by Player

Table Nuclear Medicine/Radiopharmaceuticals Product Type by Player

Table Mergers & Acquisitions, Expansion Plans

Table Lantheus Medical Imaging Profile

Table Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table Bayer Healthcare Profile

Table Bayer Healthcare Nuclear Medicine/Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table Nordion Profile

Table Nordion Nuclear Medicine/Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table Cardinal Health Profile

Table Cardinal Health Nuclear Medicine/Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table Mallinckrodt PLC Profile

Table Mallinckrodt PLC Nuclear Medicine/Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table GE Healthcare Profile

Table GE Healthcare Nuclear Medicine/Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table Eczcibasi-Monrol Nuclear Products Profile

Table Eczcibasi-Monrol Nuclear Products Nuclear Medicine/Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table IBA Molecular Imaging Profile

Table IBA Molecular Imaging Nuclear Medicine/Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table Advanced Accelerator Applications S.A. Profile

Table Advanced Accelerator Applications S.A. Nuclear Medicine/Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table Bracco Imaging S.P.A Profile

Table Bracco Imaging S.P.A Nuclear Medicine/Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table Global Nuclear Medicine/Radiopharmaceuticals Production by Type (2014-2019)

Table Global Nuclear Medicine/Radiopharmaceuticals Production Market Share by Type (2014-2019)

Figure Global Nuclear Medicine/Radiopharmaceuticals Production Market Share by Type in 2018

Table Global Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2014-2019)

Table Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Type (2014-2019)

Figure Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Type in 2018

Table Nuclear Medicine/Radiopharmaceuticals Price by Type (2014-2019)

Figure Global Nuclear Medicine/Radiopharmaceuticals Production Growth Rate of Diagnosis (2014-2019)

Figure Global Nuclear Medicine/Radiopharmaceuticals Production Growth Rate of Therapeutics (2014-2019)

Table Global Nuclear Medicine/Radiopharmaceuticals Consumption by Application (2014-2019)

Table Global Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Application (2014-2019)

Table Global Nuclear Medicine/Radiopharmaceuticals Consumption of Alpha radiation therapy (2014-2019)

Table Global Nuclear Medicine/Radiopharmaceuticals Consumption of Beta radiation therapy (2014-2019)

Table Global Nuclear Medicine/Radiopharmaceuticals Consumption of Brachytherapy (2014-2019)

Table Global Nuclear Medicine/Radiopharmaceuticals Consumption by Region (2014-2019)

Table Global Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Region (2014-2019)

Table United States Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export, Import (2014-2019)

Table Europe Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export, Import (2014-2019)

Table China Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export, Import (2014-2019)

Table Japan Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export, Import (2014-2019)

Table India Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export, Import (2014-2019)

Table Southeast Asia Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export, Import (2014-2019)

Table Central and South America Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export, Import (2014-2019)

Table Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export, Import (2014-2019)

Table Global Nuclear Medicine/Radiopharmaceuticals Production by Region (2014-2019)

Table Global Nuclear Medicine/Radiopharmaceuticals Production Market Share by Region (2014-2019)

Figure Global Nuclear Medicine/Radiopharmaceuticals Production Market Share by Region (2014-2019)

Figure Global Nuclear Medicine/Radiopharmaceuticals Production Market Share by Region in 2018

Table Global Nuclear Medicine/Radiopharmaceuticals Revenue by Region (2014-2019)

Table Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Region (2014-2019)

Figure Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Region (2014-2019)

Figure Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Region in 2018

Table Global Nuclear Medicine/Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table United States Nuclear Medicine/Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table Europe Nuclear Medicine/Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table China Nuclear Medicine/Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table Japan Nuclear Medicine/Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table India Nuclear Medicine/Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table Southeast Asia Nuclear Medicine/Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table Central and South America Nuclear Medicine/Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table Key Raw Materials Introduction of Nuclear Medicine/Radiopharmaceuticals

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Market Concentration Rate of Raw Materials

Figure Manufacturing Cost Structure Analysis

Figure Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceuticals

Figure Nuclear Medicine/Radiopharmaceuticals Industrial Chain Analysis

Table Raw Materials Sources of Nuclear Medicine/Radiopharmaceuticals Major Players in 2018

Table Downstream Buyers

Figure Global Nuclear Medicine/Radiopharmaceuticals Production and Growth Rate Forecast (2019-2026)

Figure Global Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate Forecast (2019-2026)

Figure Global Nuclear Medicine/Radiopharmaceuticals Price and Trend Forecast (2019-2026)

Table United States Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export and Import Forecast (2019-2026)

Table Europe Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export and Import Forecast (2019-2026)

Table China Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export and Import Forecast (2019-2026)

Table Japan Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export and Import Forecast (2019-2026)

Table India Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export and Import Forecast (2019-2026)

Table Southeast Asia Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export and Import Forecast (2019-2026)

Table Southeast Asia Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export and Import Forecast (2019-2026)

Table Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export and Import Forecast (2019-2026)

Table Global Nuclear Medicine/Radiopharmaceuticals Market Production Forecast, by Type

Table Global Nuclear Medicine/Radiopharmaceuticals Production Volume Market Share Forecast, by Type

Table Global Nuclear Medicine/Radiopharmaceuticals Market Revenue Forecast, by Type

Table Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share Forecast, by Type

Table Global Nuclear Medicine/Radiopharmaceuticals Price Forecast, by Type

Table Global Nuclear Medicine/Radiopharmaceuticals Market Production Forecast, by Application

Table Global Nuclear Medicine/Radiopharmaceuticals Production Volume Market Share Forecast, by Application

Table Global Nuclear Medicine/Radiopharmaceuticals Market Revenue Forecast, by Application

Table Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share Forecast, by Application

Table Global Nuclear Medicine/Radiopharmaceuticals Price Forecast, by Application

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370